182 patients suffering from symptomatic, mostly recurrent bacterial vaginitis were treated with SolcoTrichovac. The patients were mostly in the ‘under 25 years’ age group and almost 50% of them were on oral contraceptives. SolcoTrichovac immunotherapy resulted in a marked normalization of vaginal flora, reappearance of normal lactobacilli (71 %) and a drop in the vaginal pH as well as a significant decrease in subjective and objective clinical signs and symptoms (85 and 93%, respecitive